A Case Report of Saccharomyces cerevisiae Fungemia in a Premature Infant Following Probiotic Treatment
Case report Jaewoong Lee1, Hyunjung Kim1, Hae Kyung Lee1, Yeon-Joon Park2 Department of Laboratory Medicine, 1Uijeongbu St. Mary’s Hospital, Uijeongbu, 2Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Corresponding to Hae Kyung Lee, E-mail: hkl@catholic.ac.kr Ann Clin Microbiol 2020;23(3):155-158. https://doi.org/10.5145/ACM.2020.23.3.5Received on 14 July 2020, Revised on 6 August 2020, Accepted on 6 August 2020, Published on 20 September 2020.Copyright © Korean Society of Clinical Microbiology. Abstract Probiotics are used to restore and maintain the healthy intestinal microflora. Although Saccharomyces cerevisiae (SC) is considered as a non-pathogenic yeast, administration of SC as a probiotic is associated with a rare cause of fungemia in immunocompromised patients with central venous catheter insertion. We encountered a case of SC fungemia in a premature infant who presented with respiratory distress syndrome and had undergone central venous catheterization. Keywords Central venous catheter, Fungemia, Premature birth , Probiotics, Saccharomyces cerevisiae Probiotics are live
